ATE324105T1 - Verwendung von cyclooxygenase-2-inhibitoren zur behandlung von entzündungserkrankungen von kopf und nacken - Google Patents
Verwendung von cyclooxygenase-2-inhibitoren zur behandlung von entzündungserkrankungen von kopf und nackenInfo
- Publication number
- ATE324105T1 ATE324105T1 AT99937419T AT99937419T ATE324105T1 AT E324105 T1 ATE324105 T1 AT E324105T1 AT 99937419 T AT99937419 T AT 99937419T AT 99937419 T AT99937419 T AT 99937419T AT E324105 T1 ATE324105 T1 AT E324105T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclooxygenase
- neck
- head
- inhibitor
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9934398P | 1998-09-08 | 1998-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE324105T1 true ATE324105T1 (de) | 2006-05-15 |
Family
ID=22274554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99937419T ATE324105T1 (de) | 1998-09-08 | 1999-07-29 | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung von entzündungserkrankungen von kopf und nacken |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6486203B1 (de) |
| EP (1) | EP1109553B1 (de) |
| AT (1) | ATE324105T1 (de) |
| CA (1) | CA2339049C (de) |
| DE (1) | DE69931055T2 (de) |
| ES (1) | ES2258337T3 (de) |
| WO (1) | WO2000013685A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887901B1 (en) | 1993-06-15 | 2005-05-03 | Brigham & Women's Hospital, Inc. | Lipoxin compounds and their use in treating cell proliferative disorders |
| US6048897A (en) | 1993-06-15 | 2000-04-11 | Brigham And Women's Hospital | Lipoxin compounds and their use in treating cell proliferative disorders |
| US6716883B1 (en) * | 1998-12-24 | 2004-04-06 | 1333366 Ontario Inc. | Composition useful to treat periodontal disease |
| PE20010540A1 (es) * | 1999-07-30 | 2001-05-15 | Procter & Gamble | Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza |
| EP1268393A2 (de) | 2000-03-20 | 2003-01-02 | Trustees Of Boston University | Lipoxinanaloge und verfahren zur behandlung von periodontalen erkrankungen |
| HK1054296A1 (zh) * | 2000-06-13 | 2003-11-28 | Wyeth | 纾缓炎症引致慢性痛楚的植物营养素配方 |
| US6878751B1 (en) | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
| DE60236273D1 (de) | 2001-05-03 | 2010-06-17 | Cornell Res Foundation Inc | Behandlung von krankheiten, die durch hpv verursacht werden |
| US6979470B2 (en) * | 2001-07-17 | 2005-12-27 | Metaproteomics, Llc | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| WO2003039533A1 (en) | 2001-11-06 | 2003-05-15 | The Brigham And Women's Hospital, Inc. | Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| EP2361622A1 (de) | 2001-12-18 | 2011-08-31 | The Brigham and Women's Hospital | Verwendung von Lipoxinanaloga für Förderung der Zellverteidigung gegen gramnegative Infektionen |
| US7977049B2 (en) | 2002-08-09 | 2011-07-12 | President And Fellows Of Harvard College | Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| AU2003251587A1 (en) * | 2002-08-22 | 2004-03-11 | Cornell Research Foundation, Inc. | Multifunctional cox-2 inhibitors |
| US7582674B2 (en) * | 2003-05-27 | 2009-09-01 | Dsm Ip Assets B.V. | Nutraceutical compositions and use thereof |
| US20050096256A1 (en) | 2003-07-01 | 2005-05-05 | President And Fellows Of Harvard College | Compositions for manipulating the lifespan and stress response of cells and organisms |
| DE10352368A1 (de) * | 2003-11-10 | 2005-06-09 | Beiersdorf Ag | Verwendung von Licochalkon A zur Behandlung von Insektenstichen |
| DE10352367A1 (de) * | 2003-11-10 | 2005-06-09 | Beiersdorf Ag | Verwendung von Licochalkon A gegen Rosacea |
| DE10352369A1 (de) * | 2003-11-10 | 2005-06-09 | Beiersdorf Ag | Verwendung von Licocalchon A oder eines Licocalchon A enthaltenden Extraktes aus Radix Glycyrrhizae inflatae gegen postinflammatorische Hyperpigmentierung |
| DE10356869A1 (de) | 2003-12-03 | 2005-07-07 | Beiersdorf Ag | Tensidhaltige Zubereitung mit Licochalcon A |
| US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
| CN101247793B (zh) | 2003-12-29 | 2013-04-10 | 哈佛大学校长及研究员协会 | 治疗或预防肥胖和胰岛素抗性病症的组合物 |
| WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
| US20080044455A1 (en) * | 2006-08-21 | 2008-02-21 | Chaim Welczer | Tonsillitus Treatment |
| RU2335309C1 (ru) * | 2007-06-27 | 2008-10-10 | Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава | Способ комплексного лечения хронического тонзиллита |
| US9700525B2 (en) * | 2008-08-20 | 2017-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College | Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders |
| CN104367775A (zh) * | 2014-12-08 | 2015-02-25 | 田丽华 | 一种用于治疗扁桃体炎的中药 |
| WO2018011790A1 (en) * | 2016-07-11 | 2018-01-18 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro), (Volcani Center) | Treatment of follicular tonsillitis with plant extracts containing carnosic acid |
| US11103465B2 (en) | 2017-11-22 | 2021-08-31 | Ted's Brain Science, Inc. | Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4870210A (en) | 1987-12-18 | 1989-09-26 | American Home Products Corporation | Aminoguanidine derivative as anti-inflammatory agents |
| JP3207912B2 (ja) * | 1991-03-15 | 2001-09-10 | カネボウ株式会社 | コラゲナーゼ活性阻害剤 |
| US5710181A (en) | 1991-12-16 | 1998-01-20 | Washington University | Inhibition of nitric oxide formation in inflammatory bowel disease |
| US6048850A (en) | 1992-09-22 | 2000-04-11 | Young; Donald A. | Method of inhibiting prostaglandin synthesis in a human host |
| GB9602877D0 (en) * | 1996-02-13 | 1996-04-10 | Merck Frosst Canada Inc | 3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors |
| US5436265A (en) | 1993-11-12 | 1995-07-25 | Merck Frosst Canada, Inc. | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| GB2317339A (en) * | 1996-08-01 | 1998-03-25 | Procter & Gamble | Dentifrice composition containing a curcuminoid |
-
1999
- 1999-07-29 US US09/762,286 patent/US6486203B1/en not_active Expired - Fee Related
- 1999-07-29 EP EP99937419A patent/EP1109553B1/de not_active Expired - Lifetime
- 1999-07-29 AT AT99937419T patent/ATE324105T1/de not_active IP Right Cessation
- 1999-07-29 DE DE69931055T patent/DE69931055T2/de not_active Expired - Lifetime
- 1999-07-29 WO PCT/US1999/016685 patent/WO2000013685A1/en not_active Ceased
- 1999-07-29 CA CA2339049A patent/CA2339049C/en not_active Expired - Fee Related
- 1999-07-29 ES ES99937419T patent/ES2258337T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1109553A1 (de) | 2001-06-27 |
| ES2258337T3 (es) | 2006-08-16 |
| WO2000013685A1 (en) | 2000-03-16 |
| DE69931055T2 (de) | 2006-12-07 |
| US6486203B1 (en) | 2002-11-26 |
| EP1109553B1 (de) | 2006-04-26 |
| EP1109553A4 (de) | 2003-12-10 |
| CA2339049C (en) | 2010-02-23 |
| DE69931055D1 (de) | 2006-06-01 |
| CA2339049A1 (en) | 2000-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69931055D1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung von entzündungserkrankungen von kopf und nacken | |
| ATE312635T1 (de) | Ventilanordnung | |
| DE60128540D1 (de) | Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen | |
| DE69613840D1 (de) | Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle | |
| SV1995000007A (es) | Derivados del acido micofenolico 5-substituidos. | |
| ATE429922T1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
| ATE371462T1 (de) | Verbesserung der herstellung von endogenen gonadotropin | |
| TR200101307T2 (tr) | Antranilik asit amidler ve ilaç olarak kullanılmaları. | |
| SE9301489D0 (sv) | Veterinary composition | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| DK1227820T3 (da) | Oligosaccharidaldonsyrer og topisk anvendelse deraf | |
| DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
| PT867184E (pt) | Utilizacao de tiagabina para o tratamento de desordens do sono | |
| ATE199645T1 (de) | Kombination von nekrose-induzierenden substanzen mit substanzen, die durch nekrosen aktiviert werden, zur selektiven therapie von tumoren und entzündlichen erkrankungen | |
| ATE267583T1 (de) | Arzneizubereitungen zur behandlung sexueller funktionsstörungen | |
| IT1303671B1 (it) | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio | |
| ATE177646T1 (de) | Protein präparate zur verhütung und behandlung van periodontitis und sonstigen bakteriellen erkrankungen der mundhöhle | |
| ES2139061T3 (es) | Preparado para la piel y las mucosas, con contenido en acido nitrico. | |
| DK1343472T3 (da) | Thixotropisk næsespray | |
| NO20002649L (no) | Anvendelse av en blanding av diol og en alfa-hydroksysyre for behandling av hyperkeratotiske hudsykdommer | |
| FI20000635A0 (fi) | COMT-inhibiittoreiden käyttö analgeettina | |
| IL138290A0 (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
| HUP0104652A2 (hu) | Nátrium/hidrogén-csere inhibitorok alkalmazása öregkori szervi rendellenességek és öregkori betegségek megakadályozására és az élet meghosszabbítására alkalmas gyógyszerkészítmények előállítására | |
| BR0308795A (pt) | Amidas do ácido sulfamico | |
| CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |